The doll is called Licca-chan ... Since April 2021, when the company developed a curative drug for alopecia areata, Nishimura has worked to broaden understanding of the disease.

Pharmacokinetics and pharmacodynamic properties of a parent drug and its active or inactive metabolites are greatly affected in patients with kidney disease and its resulting uremia. Hemodialysis ...